Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

U.S. state AGs sue six cos, including Mylan, Teva, over drug pricing

Connecticut and 19 other states filed a lawsuit against Mylan, Teva Pharmaceuticals and four other generic drug makers saying they entered into illegal conspiracies that raised prices on two common generic drugs, the New York state attorney general’s office said in a statement.

Read More »

New diabetes guidelines imminent, Jardiance sales may surge

Two leading U.S. medical societies are poised to issue new diabetes treatment guidelines that are expected to reflect the lifesaving cardiovascular effects of Eli Lilly’s Jardiance.

Read More »

Novo, Sanofi face off with new diabetes drugs

Rivals Novo Nordisk and Sanofi have won U.S. approval for new combination drugs to treat diabetes, sparking a fresh battle for sales in a fiercely competitive market.

Read More »

Intarcia files U.S. approval for diabetes implant

Intarcia Therapeutics Inc. submitted a marketing application for its matchstick-size implantable drug-delivery pump for diabetes to the U.S. FDA.

Read More »

Drug price pressure helped sink Novo’s insulin pill

Commercial rather than technical hurdles ultimately torpedoed Novo Nordisk’s bid to make an oral form of insulin.

Read More »

Two Promising Strategies to Leverage Real-Time Digital Data to Improve Patient Marketing

A review about two promising applications of digital data to improve patient marketing, plus a third “low-hanging fruit” tactic most brands should explore.

Read More »

Drugmakers under fire for possible U.S. price fixing

Two prominent U.S. lawmakers called on federal antitrust regulators to probe whether Sanofi SA, Eli Lilly and Co., Merck & Co. Inc. and Novo Nordisk A/S colluded to set prices for insulin and other diabetes drugs.

Read More »

Industry funded studies do not find sweet drinks linked to obesity, diabetes

Do sugar-sweetened beverages like soda and fruit drinks cause obesity and diabetes? The answer may depend on who funds the research asking the question.

Read More »

Google’s Verily to Tackle Zika

Verily, Google’s life sciences division, aims to eliminate the threat of the mosquito-borne Zika virus by figuring out how to prevent the pesky pests from reproducing.

Read More »

Hanmi Pharma Inks $910M Deal with Genentech

Genentech, a member of the Roche Group, licensed HM95573 from Seoul, South Korea-based Hanmi Pharmaceutical Co. for a deal that could hit $910 million.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

August 2019 Focus: AI, AR/VR, Top 200 Medicines, Lions Health Takeaways, and more!


Ad Right Bottom